about
ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcomePolymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid diseaseTERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomasSelenium and Thyroid Disease: From Pathophysiology to Treatment.Prognostic biomarkers in thyroid cancer.Telomerase promoter mutations in cancer: an emerging molecular biomarker?[Prevalence of Dental Caries in Type 1 Diabetic Patients Treated with Insulin Pump].pmTOR is a marker of aggressiveness in papillary thyroid carcinomas.Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later.NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features.Long-term survival in a patient with brain metastases of papillary thyroid carcinoma.Laparoscopic adrenalectomy as an effective approach to massive bilateral pheochromocytomas.TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: added value in patient prognosis?IntroductionOther Rare Tumours and Tumour-Like LesionsRare Familial TumoursRare Follicular TumoursRare Papillary Thyroid CarcinomasSmall Cell TumoursTherapeutic OptionsThe role of ablative treatment in differentiated thyroid cancer managementPrevalência de Lesões de Cárie de Doentes com Diabetes Mellitus Tipo 1 Tratados com Múltiplas Administrações de Insulina e de Indivíduos sem DiabetesThe diseases we cause: Iatrogenic illness in a department of internal medicineOutcome and long-term follow-up of adrenal lesions in multiple endocrine neoplasia type 1
P50
Q26778154-7111649E-7CA8-435E-BFDD-A5F8CCE2C213Q34051020-D73EF513-6321-4387-A3E5-2D7F94351D34Q34313648-846E79E8-5CBE-49D4-930A-18D1D1D311C6Q37640141-F96467B6-5BE8-4811-9FAA-50491DBADA6DQ38184374-F39A8B97-3DF6-4F2D-9937-F6EF9FE053BAQ38232447-AB6D24DE-A7C0-4A36-81AD-70D9DB5D71D9Q40443655-D9430D81-EFCB-42F8-B903-DA7DFE34A1A7Q40602311-D20552B0-A3BE-457F-9C60-94BD8149BE98Q44740153-A00244D5-0F99-453C-9CA5-CA83D45AAFA6Q47212889-4C00C6F9-A7D5-4C28-B34A-CBFB68EFE5D1Q48847781-677702F8-64BB-4D6E-9647-630673C2CC60Q50203337-5E88AD0B-295D-41CF-B074-EB714DFDA2D0Q51092203-8B742C5D-0640-40BD-841A-BFD8D22FCA57Q55068563-3E1368E8-F3C4-451E-B38C-6733DD303376Q59600637-AAE1B69C-9ACB-487D-B309-7F4C5AF375C2Q59600641-9F7EDF20-641D-4CF6-A595-17561187D418Q59600642-30032F6D-0E63-42C5-80F3-669467DD5FBAQ59600644-D6FB9C28-7A75-4474-8E33-E13F1A8CC83FQ59600645-21F1C734-DC7A-499F-AFBE-94431283DAFCQ59600648-8549E6F1-A134-4FAE-BA53-C70E4095CD0EQ59600651-774C5354-B593-4112-9449-1DE9C68D1AB2Q60526771-F6584DAB-3C73-4973-B387-458F806CE214Q61045815-000A3C21-4CE0-4FA6-8AB7-74B811797662Q80784477-8495080A-45E9-4963-B8A5-F18A6649FF0FQ93093647-2DD1FAC5-0631-429B-98E2-5967AD69F476
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Miguel Melo
@ast
Miguel Melo
@en
Miguel Melo
@es
Miguel Melo
@nl
Miguel Melo
@sl
type
label
Miguel Melo
@ast
Miguel Melo
@en
Miguel Melo
@es
Miguel Melo
@nl
Miguel Melo
@sl
prefLabel
Miguel Melo
@ast
Miguel Melo
@en
Miguel Melo
@es
Miguel Melo
@nl
Miguel Melo
@sl
P1053
L-2106-2014
P106
P1153
8257325600
P21
P31
P3829
P496
0000-0002-8365-1380